Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-FR
Language English French
Date Updated 2020-01-11 2020-01-08
Drug Identification Number 02229566 02229566
Brand name TOMUDEX TOMUDEX
Common or Proper name TOMUDEX TOMUDEX
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients RALTITREXED RALTITREXED
Strength(s) 2MG 2MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2mg vial 2mg vial
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-22 2019-11-22
Estimated end date 2020-01-13
Actual end date 2020-01-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Inventory is on strict allocation
Health Canada comments